OmaSp´s key figures 2015–2019

The financial statements of OmaSp have been prepared in accordance with International Financial Reporting Standards. OmaSp has applied IFRS since 2016. 2015 financials were restated according to IFRS standards in 2016. Beginning from 1st of January 2018, OmaSp has reported according to the IFRS 9 standard. Before 2018 OmaSp had applied the IAS 39 standard for determining the value of financial assets and liabilities.

EUR thousand, unaudited unless otherwise stated

 1.1.-31.12.20191.1.-31.12.20181.1.-31.12.
2017
1.1.-31.12.
2016
1.1.-31.12.
2015
Net interest income 57 52249 35139,317(136,547(131,733
Profit before taxes32 68424 97630,379(120,611(118,420
Total operating income 92 573 75 95874,091(160,339(154,352
Total operating expenses50 30947 237-41,112(1-35,531(1-32,338
Cost/income ratio54,4 %62,2 %55.5 %58.9 %59.5 %
Balance sheet total3 416 5302 914 6612,726,567(12,150,768(11,932,328
Equity, total319 865 290 330241,484(1221,071(1202,126
Return on assets, ROA %0,9 %0,7 %1.0 %0.8 %0.8 %
Return on equity, ROE %9,0 %7,6 %10.4 %7.6 %7.8 %
Equity ratio %9,4 %10,0 %8.9 %10.3 %10.5 %
Sovency ratio, (TC) %17,3 %19,3 %18.9 %(2(319.1 %(1(220.2 %(1(2
Core capital ratio, (CET1) %16,8 %18,4 %17.6 %(2 (318.6 %(1(219.4 %(1(2
Tier 1 capital ratio, (T1) %

16,8 %

18,4 %

17.6 %(2 (318.6 %(1(219.4 %(1(2
Impairment losses on financial assets- 9 567 - 3 746-2,600(1-4,197(1-3,594
Number of employees at the end of the accounting period279293270229252
Average number of employees300288256246
Liquidity coverage ratio (LCR) %140,1 %134,8 %280.3 %(2 111.3 %(2
Earnings per share (EPS), EUR0,93 0,780,980.650,63

1) Audited 2) Parent company 3) The figures do not correspond to the figures presented in the financial statement of 2017, since the OmaSp has rectified the key figures for core capital and solvency. The shares subscribed for in the 2017 personnel offering are not included in the core capital. 

Alternative key figures excluding items affecting comparability:

 201920182017

Comparable pre-tax profit

28 04526 21019 599

 

Comparable cost-benefit ratio

56,7 %61,1 %64,9 %

Comparable earnings per share (EPS), EUR

0,760,820,63

Comparable return on equity, ROE %

7,4 %8,0 %6,7 %